Industry
Pension Funds and Sovereign Wealth
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Pension Funds & Sovereign Wealth
... here). Here are the five most-read stories on privateequityinternational.com this year: - CDPQ poaches PSP private equity senior director In October, we broke the news ...
... a Belgrade, Minn.-based adventure-hospitality brand. Financial terms weren't disclosed. OTHER DEALS [ts_bullet_primary] Temasek Holdings Pte is in talks about a potential sale of its stake ...
... to sell a 30pc stake in the conglomerate to the Canada Pension Plan Investment Board (CPPIB) for £675m. The stake sale means that a float ...
... billion. Pension plans that have recently hired AllianceBernstein include State of Wisconsin Investment Board, Madison, which invested $375 million with AllianceBernstein in the "funds alpha" ...
... a memorandum of understanding between SoftBank and the Public Investment Fund of the Kingdom of Saudi Arabia (PIF). Under terms of the MOU, SoftBank will ...
... any regulator, but in a civil suit brought by investors, led by TIAA-CREF, the teacher retirement services provider. The 177-page suit claims that ARCP's accounting ...
... manager based in Singapore, has received a commitment worth $500 million from Temasek Holdings, Singapore's sovereign wealth fund, to start a hedge fund seeding venture, ...
... to buy Ignis Asset Management Ltd. from closed life fund consolidator Phoenix Group Holdings Ltd. in what would be the latest in a recent string ...
... oversubscribed at its hard cap. Investors include TIAA-CREF, the $67.9 billion Washington State Investment Board and Oregon Investment Council, which runs the $63.1 billion Oregon ...
... 2012 was also marked by the launch of the partnership with Eli Lilly Group and the clinical development in line with the established planning. Finally, ...
Want to see the full history of news? Upgrade to RelSci Professional now!
Start My Free Trial